Year: 2024 | Month: December | Volume: 11 | Issue: 12 | Pages: 554-572
DOI: https://doi.org/10.52403/ijrr.20241261
Nanopharmaceuticals: A Review on Patent Expiring Novel Drugs and its challenges to Generic Drug Development
J. Lavanya1, I. Meghana2, M. Nimitha3, T. Sathish Kumar4
1,2,3,4Department of Pharmaceutical Chemistry, CMR College of Pharmacy, Hyderabad, Telangana, India
Corresponding Author: Dr. J. Lavanya
ABSTRACT
Engineered nanoparticles are employed in nanopharmaceuticals, an advanced class of medicine, to improve drug delivery, solubility, bioavailability, and targeting efficiency while minimizing harmful effects. After overcoming many obstacles such as economic downturns and market failures, very few nanopharmaceuticals are getting authorized effectively. The manufacturing of generic pharmaceuticals becomes more competitive as soon as the patents on these marketed medications expire. For the community of low-income individuals, these generic medications provide accessible substitutes for expensive pharmaceuticals. Manufacturers of generic drugs must overcome obstacles before being allowed to enter the market. This review addresses upon medications whose patents are about to expire as well as the difficulties in developing generic pharmaceuticals.
Keywords: Nanopharmaceuticals, patent expiration, drug delivery, Economic down turns, obstacles, nanomedicine, generic drug, developing generic pharmaceuticals, CDDS: Conventional Drug Delivery System.
[PDF Full Text]